Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for ESTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2018. Start Trial.
Date Value
May 31, 2026 75.42%
April 30, 2026 75.42%
March 31, 2026 75.42%
February 28, 2026 75.42%
January 31, 2026 75.42%
December 31, 2025 75.42%
November 30, 2025 75.42%
October 31, 2025 75.42%
September 30, 2025 75.42%
August 31, 2025 75.42%
July 31, 2025 75.42%
June 30, 2025 75.42%
May 31, 2025 75.42%
April 30, 2025 75.42%
March 31, 2025 75.42%
February 28, 2025 75.42%
January 31, 2025 75.42%
December 31, 2024 75.42%
November 30, 2024 75.42%
October 31, 2024 75.42%
September 30, 2024 75.42%
August 31, 2024 75.42%
July 31, 2024 75.42%
June 30, 2024 75.42%
May 31, 2024 75.42%
Date Value
April 30, 2024 75.42%
March 31, 2024 75.42%
February 29, 2024 75.42%
January 31, 2024 75.42%
December 31, 2023 75.42%
November 30, 2023 75.42%
October 31, 2023 73.91%
September 30, 2023 73.91%
August 31, 2023 73.91%
July 31, 2023 73.91%
June 30, 2023 73.91%
May 31, 2023 73.91%
April 30, 2023 73.91%
March 31, 2023 73.91%
February 28, 2023 73.91%
January 31, 2023 73.91%
December 31, 2022 73.91%
November 30, 2022 73.91%
October 31, 2022 73.91%
September 30, 2022 73.91%
August 31, 2022 73.91%
July 31, 2022 73.91%
June 30, 2022 73.91%
May 31, 2022 73.91%
April 30, 2022 73.91%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
QuidelOrtho Corp. 94.30%
Abbott Laboratories 39.63%
AngioDynamics, Inc. 82.98%
Alphatec Holdings, Inc. 73.51%
AtriCure, Inc. 77.21%